---
title: "Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/270687121.md"
description: "Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug"
datetime: "2025-12-24T04:18:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270687121.md)
  - [en](https://longbridge.com/en/news/270687121.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270687121.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/270687121.md) | [繁體中文](https://longbridge.com/zh-HK/news/270687121.md)


# Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug



### 相关股票

- [APELOA (000739.CN)](https://longbridge.com/zh-CN/quote/000739.CN.md)

## 相关资讯与研究

- [Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics](https://longbridge.com/zh-CN/news/268186949.md)
- [Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection](https://longbridge.com/zh-CN/news/263996571.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/zh-CN/news/278010381.md)
- [Orient Securities receives regulatory approval for bond issuance](https://longbridge.com/zh-CN/news/278522279.md)
- [Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding](https://longbridge.com/zh-CN/news/278291727.md)